期刊文献+

沉默人趋化因子受体1基因对小鼠血管平滑肌细胞增殖的作用 被引量:3

Role of CMKLR1 Receptor in the Proliferation of Mouse Vascular Smooth Muscle Cells
下载PDF
导出
摘要 目的利用慢病毒构建人趋化因子受体1(chemokine receptor-like 1,CMKLR1)基因缺陷性小鼠血管平滑肌细胞株,观察沉默CMKLR1基因后血管平滑肌细胞的增殖情况。方法将正常血管平滑肌细胞、CMKLR1基因干扰对照血管平滑肌细胞株、CMKLR1基因缺陷性血管平滑肌细胞株分成正常组、增殖组、对照组和CMKLR1沉默组,增殖组、对照组、CMKLR1沉默组加入血小板源性生长因子-BB促进增殖,采用细胞计数和细胞增殖实验(Brdu法)检测血管平滑肌细胞增殖。结果增殖组血管平滑肌细胞的细胞数目和Brd U A值显著高于正常组(P均<0.05);与正常组相比,CMKLR1沉默组的血管平滑肌细胞数目和Brd U A值显著降低(P均<0.05);与此同时,对照组与正常组之间的血管平滑肌细胞增殖情况差异无统计学意义(P>0.05)。结论沉默CMKLR1受体可以抑制小鼠血管平滑肌细胞的增殖。 Objective To explore the proliferation property of vascular smooth muscle cells in the stable CMKLR1 gene knock - down mouse vascular smooth muscle cells (VSMCs) line. Methods The normal VSMCs, CMKLR1 gene interfering control VSMCs line, stable CMKLR1 gene knockdown VSMCs line were divided into nromal group,PDGF group, control group and CMKLR1 knockdown group, The PDGF group,control group and CMKLR1 knockdown group were given platelet- derived growth factor- BB (PDGF- BB) to initiate proliferation of VSMCs. Cell number counting and BrdU measurement were employed to investigate the proliferation property of VSMCs. Results The VSMCs number and BrdU A value of PDGF group significantly increased which was higher than those of normal group ( both P 〈 0. 05). Compared with normal group, the CMKLR1 knockdown group obviously decreased in VSMCs number and BrdU A value ( both P 〈 0.05). Simultaneously, there was no significant difference in the proliferation of VSMCs between normal group and control group. Conclusion Inhibiting CMKLR1 signal transduction pathway can prevent the proliferation of mouse vascular smooth muscle cells.
出处 《医学研究杂志》 2016年第4期76-79,84,共5页 Journal of Medical Research
基金 深圳市重点资助科技计划(201201022)
关键词 血管平滑肌细胞 人趋化因子受体1 信号通路 增殖 Vascular smooth muscle cell Chemerin Signal transduction pathway Proliferation
  • 相关文献

参考文献17

  • 1Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting:approach to therapy[J].Circ J,2011,75(6):1287-1296. 被引量:1
  • 2Peng L, Yu Y, Liu J, et al. The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide[J]. J Alzheimers Dis, 2015,43(1):227-242. 被引量:1
  • 3Mattern A, Zellmann T, Beck-Sickinger AG. Processing, signaling, and physiological function of chemerin[J].IUBMB Life, 2014, 66(1):19-26. 被引量:1
  • 4Ernst MC, Sinal CJ. Chemerin:at the crossroads of inflammation and obesity[J].Trends Endocrinol Metab, 2010,21(11):660-667. 被引量:1
  • 5Spiroglou SG, Kostopoulos CG, Varakis JN, et al. Adipokines in periaortic and epicardial adipose tissue:differential expression and relation to atherosclerosis[J].J Atheroscler Thromb,2010, 17(2):115-130. 被引量:1
  • 6Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome[J].Intern Med, 2011,50(10):1093-1097. 被引量:1
  • 7Dong S, Xiong W, Yuan J,et al.MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-κB expression[J].Mol Med Rep, 2013,8(2):407-412. 被引量:1
  • 8Mattern A, Zellmann T, Beck-Sickinger AG. Processing, signaling, and physiological function of chemerin[J].IUBMB Life, 2014,66(1):19-26. 被引量:1
  • 9Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism[J].Cytokine Growth Factor Rev, 2011,22(5-6):331-338. 被引量:1
  • 10Roman AA, Parlee SD, Sinal CJ.Chemerin:a potential endocrine link between obesity and type 2 diabetes[J].Endocrine, 2012,42(2):243-251. 被引量:1

同被引文献26

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部